Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare multiple congenital anomalies/dysmorphic syndrome with intellectual disability characterized by severe congenital contractures of the limbs and face, hypotonia, neonatal respiratory distress, and global developmental delay. Dysmorphic facial features include downslanting palpebral fissures, broad nasal bridge, large nares, long philtrum, and deep nasolabial folds, among others. Limb deformities (camptodactyly, clubfoot), short neck, scoliosis, as well as seizures have also been reported. Brain MRI may show cerebral and cerebellar atrophy in some cases.
Features include always present findings: Long philtrum, Short columella, Motor delay, and Delayed speech and language development and others; and very common findings: Anteverted nares, Gastroesophageal reflux, Prominent nasolabial fold, and Constipation and others. 39 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 7 | Shrinkage of the cerebellum (cerebellar atrophy), Hip contracture, Low muscle tone (hypotonia) |
NALCN encodes sodium leak channel, non-selective (1,738 aa). Voltage-gated ion channel responsible for the resting Na(+) permeability that controls neuronal excitability. Highest expression in Brain Cerebellar Hemisphere (17.0 TPM) and Brain Cerebellum (14.5 TPM).
Congenital contractures of the limbs and face, hypotonia, and developmental delay is associated with mutations in the NALCN gene on chromosome 13.
The NALCN protein participates in UNC79:UNC80:NALCN transports Na+ extracellular region to cytosol pathway.
NALCN is classified as a druggable target (Druggable Genome, G Protein Coupled Receptor, Ion Channel, Kinase, and Transporter categories) with score 1.7.
Genetic testing for NALCN is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 10 very common features, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital contractures of the limbs and face, hypotonia, and developmental delay.
106 publications have been identified in PubMed for congenital contractures of the limbs and face, hypotonia, and developmental delay. Kisho has analyzed 63 by research type. Research spans Review / Meta-Analysis (44%), Case Report / Case Series (29%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 28 |
Data assembled from 6 of 12 sources · Last updated Sep 21, 2026, 2:33 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital contractures of the limbs and face, hypotonia, and developmental delay
Brain and nerves | 4 | Seizure, Brain shrinkage (cerebral atrophy), Delayed speech and language development |
Digestive system | 2 | Gastroesophageal reflux, Constipation |
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Neonatal respiratory distress |
Pregnancy and birth | 2 | Congenital contracture, Neonatal respiratory distress |
Eyes | 1 | Strabismus |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Patient case studies | 18 | 29% |
Laboratory research | 10 | 16% |
Disease patterns and progression | 6 | 10% |
Clinical study results | 1 | 2% |
OBrien MP (2026). [PMID: 40334032](https://pubmed.ncbi.nlm.nih.gov/40334032/). *Unknown Journal*. [Basic Science / Preclinical]
Tana C (2026). [PMID: 41980458](https://pubmed.ncbi.nlm.nih.gov/41980458/). *J Fr Ophtalmol*. [Review / Meta-Analysis]
Fukumori F (2026). [PMID: 41702874](https://pubmed.ncbi.nlm.nih.gov/41702874/). *Prenatal diagnosis*. [Case Report / Case Series]
Reena (2026). [PMID: 42135224](https://pubmed.ncbi.nlm.nih.gov/42135224/). *Anesth Pain Med (Seoul)*. [Case Report / Case Series]
Alani M (2026). [PMID: 32809723](https://pubmed.ncbi.nlm.nih.gov/32809723/). *Unknown Journal*. [Epidemiology / Natural History]
Eyraud C (2026). [PMID: 41854049](https://pubmed.ncbi.nlm.nih.gov/41854049/). *Pediatric pulmonology*. [Review / Meta-Analysis]
McGivern B (2025). [PMID: 39600096](https://pubmed.ncbi.nlm.nih.gov/39600096/). *HGG Adv*. [Epidemiology / Natural History]
Ohno K (2025). [PMID: 40533459](https://pubmed.ncbi.nlm.nih.gov/40533459/). *Journal of human genetics*. [Review / Meta-Analysis]
Santos JG (2025). [PMID: 39923770](https://pubmed.ncbi.nlm.nih.gov/39923770/). *Anesthesia and pain medicine*. [Case Report / Case Series]
Sun W (2025). [PMID: 40066690](https://pubmed.ncbi.nlm.nih.gov/40066690/). *Ann Med*. [Review / Meta-Analysis]